Literature DB >> 21920542

Cardiovascular risk and insulin resistance in childhood cancer survivors.

Julia Steinberger1, Alan R Sinaiko, Aaron S Kelly, Wendy M Leisenring, Lyn M Steffen, Pamela Goodman, Daniel A Mulrooney, Andrew C Dietz, Antoinette Moran, Joanna L Perkins, K Scott Baker.   

Abstract

OBJECTIVE: Increased cardiovascular (CV) risk has been reported in adults who are childhood cancer survivors (CCS). We sought to determine the emergence of CV risk factors in CCS while still children. STUDY
DESIGN: CCS in remission ≥5 years from cancer diagnosis (n=319, age=14.5 years) and their siblings (control subjects, n=208, age=13.6 years) participated in this cross-sectional study of CV risk, which included physiologic assessment of insulin sensitivity/resistance (hyperinsulinemic euglycemic clamp). Adjusted comparisons between CCS major diagnoses (leukemia [n=110], central nervous system tumors [n=82], solid tumors [n=127]) and control subjects were performed with linear regression for CV risk factors and insulin sensitivity.
RESULTS: Despite no significant differences in weight and body mass index, CCS had greater adiposity (waist [73.1 versus 71.1 cm, P=.02]; percent fat [28.1 versus 25.9%, P=.007]), lower lean body mass (38.4 versus 39.9 kg, P=.01) than control subjects. After adjustment for adiposity, CCS had higher total cholesterol level (154.7 versus 148.3 mg/dL, P=.004), low-density lipoprotein cholesterol level (89.4 versus 83.7 mg/dL, P=.002), and triglyceride level (91.8 versus 84 mg/dL, P=.03) and were less insulin sensitive (insulin stimulated glucose uptake, measure of insulin resistance, adjusted for lean body mass 12.1 versus 13.4 mg/kg/min, P=.002) than control subjects.
CONCLUSIONS: CCS have greater CV risk than healthy children. Because CV risk factors track from childhood to adulthood, early development of altered body composition and decreased insulin sensitivity in CCS may contribute significantly to their risk of early CV morbidity and mortality. Copyright Â
© 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21920542      PMCID: PMC3246569          DOI: 10.1016/j.jpeds.2011.08.018

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  28 in total

Review 1.  Follow-up report on the diagnosis of diabetes mellitus.

Authors:  Saul Genuth; K G M M Alberti; Peter Bennett; John Buse; Ralph Defronzo; Richard Kahn; John Kitzmiller; William C Knowler; Harold Lebovitz; Ake Lernmark; David Nathan; Jerry Palmer; Robert Rizza; Christopher Saudek; Jonathan Shaw; Michael Steffes; Michael Stern; Jaako Tuomilehto; Paul Zimmet
Journal:  Diabetes Care       Date:  2003-11       Impact factor: 19.112

Review 2.  Pediatric cancer survivors: Past history and future challenges.

Authors:  Anna T Meadows
Journal:  Curr Probl Cancer       Date:  2003 May-Jun       Impact factor: 3.187

3.  American Academy of Pediatrics. National Cholesterol Education Program: Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents.

Authors: 
Journal:  Pediatrics       Date:  1992-03       Impact factor: 7.124

4.  Predicting cardiovascular risk in young adulthood from the metabolic syndrome, its component risk factors, and a cluster score in childhood.

Authors:  Aaron S Kelly; Julia Steinberger; David R Jacobs; Ching-Ping Hong; Antoinette Moran; Alan R Sinaiko
Journal:  Int J Pediatr Obes       Date:  2010-11-11

5.  Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance.

Authors:  C Hollenbeck; G M Reaven
Journal:  J Clin Endocrinol Metab       Date:  1987-06       Impact factor: 5.958

6.  Co-existence of severe insulin resistance and hyperinsulinaemia in pre-adolescent obese children.

Authors:  S Caprio; M Bronson; R S Sherwin; F Rife; W V Tamborlane
Journal:  Diabetologia       Date:  1996-12       Impact factor: 10.122

7.  Relation of weight and rate of increase in weight during childhood and adolescence to body size, blood pressure, fasting insulin, and lipids in young adults. The Minneapolis Children's Blood Pressure Study.

Authors:  A R Sinaiko; R P Donahue; D R Jacobs; R J Prineas
Journal:  Circulation       Date:  1999-03-23       Impact factor: 29.690

8.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

9.  Relationship between insulin resistance and abnormal lipid profile in obese adolescents.

Authors:  J Steinberger; C Moorehead; V Katch; A P Rocchini
Journal:  J Pediatr       Date:  1995-05       Impact factor: 4.406

10.  Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome.

Authors:  E Ferrannini; S M Haffner; B D Mitchell; M P Stern
Journal:  Diabetologia       Date:  1991-06       Impact factor: 10.122

View more
  33 in total

Review 1.  Long-term complications in adolescent and young adult leukemia survivors.

Authors:  K Scott Baker; Karen L Syrjala
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  Impact of treatment exposures on cardiovascular risk and insulin resistance in childhood cancer survivors.

Authors:  K Scott Baker; Eric J Chow; Pamela J Goodman; Wendy M Leisenring; Andrew C Dietz; Joanna L Perkins; Lisa Chow; Alan Sinaiko; Antoinette Moran; Anna Petryk; Julia Steinberger
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-09-05       Impact factor: 4.254

3.  Energy balance and fitness in adult survivors of childhood acute lymphoblastic leukemia.

Authors:  Kirsten K Ness; James P DeLany; Sue C Kaste; Daniel A Mulrooney; Ching-Hon Pui; Wassim Chemaitilly; Robyn E Karlage; Jennifer Q Lanctot; Carrie R Howell; Lu Lu; Deo Kumar Srivastava; Leslie L Robison; Melissa M Hudson
Journal:  Blood       Date:  2015-03-26       Impact factor: 22.113

4.  Paediatric cardio-oncology: epidemiology, screening, prevention, and treatment.

Authors:  Eric J Chow; Kasey J Leger; Neel S Bhatt; Daniel A Mulrooney; Colin J Ross; Sanjeev Aggarwal; Neha Bansal; Matthew J Ehrhardt; Saro H Armenian; Jessica M Scott; Borah Hong
Journal:  Cardiovasc Res       Date:  2019-04-15       Impact factor: 10.787

Review 5.  Childhood cancer survivorship: an update on evolving paradigms for understanding pathogenesis and screening for therapy-related late effects.

Authors:  Saro H Armenian; Leslie L Robison
Journal:  Curr Opin Pediatr       Date:  2013-02       Impact factor: 2.856

Review 6.  Children's Oncology Group's 2013 blueprint for research: survivorship and outcomes.

Authors:  Saro H Armenian; Wendy Landier; Melissa M Hudson; Leslie L Robison; Smita Bhatia
Journal:  Pediatr Blood Cancer       Date:  2012-12-19       Impact factor: 3.167

7.  Endothelial health in childhood acute lymphoid leukemia survivors: pilot evaluation with peripheral artery tonometry.

Authors:  Kathy Ruble; Catherine L Davis; Hae-Ra Han
Journal:  J Pediatr Hematol Oncol       Date:  2015-03       Impact factor: 1.289

8.  Feasibility and preliminary efficacy of the effects of flavanoid-rich purple grape juice on the vascular health of childhood cancer survivors: a randomized, controlled crossover trial.

Authors:  Cindy K Blair; Aaron S Kelly; Julia Steinberger; Lynn E Eberly; Char Napurski; Kim Robien; Joseph P Neglia; Daniel A Mulrooney; Julie A Ross
Journal:  Pediatr Blood Cancer       Date:  2014-08-30       Impact factor: 3.167

9.  Blunted response to a growth hormone stimulation test is associated with unfavorable cardiovascular risk factor profile in childhood cancer survivors.

Authors:  Anna Petryk; K Scott Baker; Brigitte Frohnert; Antoinette Moran; Lisa Chow; Alan R Sinaiko; Lyn M Steffen; Joanna L Perkins; Lei Zhang; James S Hodges; Julia Steinberger
Journal:  Pediatr Blood Cancer       Date:  2012-09-21       Impact factor: 3.167

10.  Skeletal, neuromuscular and fitness impairments among children with newly diagnosed acute lymphoblastic leukemia.

Authors:  Kirsten K Ness; Sue C Kaste; Liang Zhu; Ching-Hon Pui; Sima Jeha; Paul C Nathan; Hiroto Inaba; Karen Wasilewski-Masker; Durga Shah; Robert J Wells; Robyn E Karlage; Leslie L Robison; Cheryl L Cox
Journal:  Leuk Lymphoma       Date:  2014-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.